Singapore Stock Market News
iX Biopharma - All in the delivery
StockFanatic
Publish date: Tue, 25 Aug 2015, 12:40 PM
StockFanatic
0 10,452
Welcome to Stockfanatic Singapore stock market and regional market news. This is a platform to share Singapore stock market and regional news to investors / man in the street. Investors can also look forward to analyst reports and brokers recommendations. Stockfanatic's Singapore stock market and regional news blog, home of investors one stop news station.
iX Biopharma is a specialty pharmaceutical company. The value of the company is in its patented WaferiX drug-delivery technology. iX currently has a portfolio of three products (all undergoing clinical development). Management projects commercialisation of its blockbuster product Wafermine in early-2018.
Short- to medium-term milestones in the eyes of management include regulatory approvals for the group‟s products while longer-term catalysts include large out-licensing contract wins (which is typical in this industry) and possible takeover offers.
Read more » More articles on Singapore Stock Market News
Market Commentary: Record highs on trade, vaccine developments
Created by StockFanatic | Aug 26, 2020
Market Commentary: Record highs on trade, vaccine developments
Created by StockFanatic | Aug 26, 2020
Market Commentary: Data help US market end week on a high note
Created by StockFanatic | Aug 24, 2020
Market Commentary: Data help US market end week on a high note
Created by StockFanatic | Aug 24, 2020
Market Commentary: And they are back, with S&P within inches of record high close
Created by StockFanatic | Aug 13, 2020
Market Commentary: And they are back, with S&P within inches of record high close
Created by StockFanatic | Aug 13, 2020
Market Commentary: US negotiations over stimulus continue amid diplomatic tensions
Created by StockFanatic | Aug 11, 2020
Market Commentary: US negotiations over stimulus continue amid diplomatic tensions
Created by StockFanatic | Aug 11, 2020
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
RHB Investment Research Reports
ST Engineering - Rolling Forward Our Valuation; Reiterate BUY
2
SGX Market Dialogues
Kopi-C With GuocoLand’s Group CEO: ‘We Have Twin Engines for Growth’
3
CEO Morning Brief
Singapore Home Sales Set for Worst Year Since Financial Crisis
4
CEO Morning Brief
DBS Posts 300% Growth in Semi-liquid Fund Sales in Greater China
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
